ImmunoPrecise Antibodies Ltd. (IPA.V)
| Previous Close | 7.85 |
| Open | 7.40 |
| Bid | 7.36 x 0 |
| Ask | 7.59 x 0 |
| Day's Range | 7.09 - 7.59 |
| 52 Week Range | 6.39 - 23.89 |
| Volume | |
| Avg. Volume | 22,603 |
| Market Cap | 145.723M |
| Beta (5Y Monthly) | -0.16 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.78 |
| Earnings Date | Mar. 15, 2022 - Mar. 21, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.00 |
- Business Wire
ImmunoPrecise Relocates European Subsidiary to LEED Certified Campus to Continue to Advance its Antibody Research Operations and Environmental Sustainability
VICTORIA, British Columbia & OSS, Netherlands, January 18, 2022--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) today announced the relocation of its IPA Europe Oss laboratories to a new multi-tenant biotech Center of Excellence at the Pivot Park Campus in Oss, Netherlands.
- Business Wire
ImmunoPrecise Antibodies Announces Grant of Stock Options
VICTORIA, British Columbia, January 17, 2022--IMMUNOPRECISE ANTIBODIES LTD. ("IPA" or the "Company") (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discovery, today announced that on January 13, 2022 its board of directors approved the grant of 15,000 stock options (the "Options") under its stock option plan to acquire up to an aggregate of 15,000 common shares in the capital of IPA ("Common Shares"). The Options were granted to a certain officer of IPA. Each Option is
- Simply Wall St.
Investors in ImmunoPrecise Antibodies (CVE:IPA) have made a impressive return of 113% over the past three years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
